AMALY — SHARIAH COMPLIANCE REPORT ================================== Symbol: GENB Report Date: 2026-04-06 Full Report: https://amaly.io/stock/GENB EXECUTIVE SUMMARY ------------------ Compliance Status: NON_COMPLIANT Quality Rating: B Description: Generate Biomedicines, Inc. (GENB) operates in the Asset Management sector within Financial Services, focusing on generative biology using machine learning for drug discovery and protein therapeutics development. The company's innovative approach to healthcare aligns potentially with Shariah principles, but limited financial disclosures as a small-cap entity hinder full assessment. Business activities are screened as compliant, with no non-permissible revenue identified. However, exclusion from all major Shariah indices due to data insufficiency and size criteria results in an overall NON_COMPLIANT status. Investors are advised to monitor future financial reporting for potential compliance improvements. Primary Compliance Concerns: - Insufficient financial data preventing accurate ratio calculations - Exclusion from Shariah indices due to small market cap and liquidity issues - Need for verification of R&D practices to ensure no haram elements Purification Requirement: 0.00% Index Inclusion: Not included in any of the major Shariah-compliant indices: S&P Dow Jones, MSCI Islamic, FTSE Shariah, or Dow Jones Islamic Market. KEY FINANCIAL METRICS ---------------------- Debt Ratio: 0.0% Liquidity Ratio: 0.0% Interest Income Ratio: 0.0% Purification Required: 0.00% INDEX INCLUSION STATUS ----------------------- S&P Shariah: EXCLUDED MSCI Islamic: EXCLUDED DJIM: EXCLUDED FTSE Shariah: EXCLUDED Total: 0 of 4 Last Verified: 2025-11-30 REPORTING PERIOD ----------------- Latest Annual Report: FY 2025 Latest Quarterly Data: Q1 2026 Trend Period: FY 2021 to FY 2025 Data Retrieved: 2026-02-27T12:00:00Z --- Full interactive report: https://amaly.io/stock/GENB Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.